ImmunoGen, Inc. · Waltham, MA United States ·(NASDAQ (GM): IMGN)
Company Description
View ImmunoGen, Inc. Locations On A US Map
This link will open in a new window
This link will open in a new window ImmunoGen is TAPping into cancer research. The firm's product candidates are TAPs, or tumor-activated prodrugs, that combine cancer-killing drugs with monoclonal antibodies and attach only to tumor cells. On its own, ImmunoGen is developing two clinical-stage compounds: IMGN242, a TAP drug candidate to treat gastrointestinal cancers and some non-small-cell lung cancers; and IMGN901, which targets small-cell lung cancer and multiple myeloma. The firm has additional candidates in clinical trials through partnerships with Genentech and Sanofi-Aventis , and it has outlicensed its TAP technology to the likes of Biogen Idec and Centocor . To read the full description, subscribe now.
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!
Key ImmunoGen, Inc. Financials
| Company Type | Public - NASDAQ (GM): IMGN Headquarters |
| Fiscal Year-End | June |
| 2009 Sales (mil.) | $28.0 |
| Employees | 210 |
ImmunoGen, Inc. Executives
17 executives listed for ImmunoGen, Inc.'s Waltham, MA location.
| Title | Name & Bio | Contact |
| Chairman | Mitchel Sayare | Network |
| President, CEO, and Director | Daniel Junius | Network |
| SVP and CFO | Gregory Perry | Network |
Competition
Competitive Landscape for ImmunoGen, Inc.
Demand often depends on the income of consumers or the profitability of business customers, because many technology products and services are expensive. The profitability of individual companies is driven by their ability to develop and market new products. Large companies often have advantages in access to capital and marketing. Small companies can compete successfully if they have expertise in a particular field of knowledge. The industry is capital-intensive: average annual revenue per worker is nearly $300,000. To read the full description, subscribe now.Top ImmunoGen, Inc. Competitors
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!